SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing ...
MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase ...
Addressing the core issues of latency and integration in developing audio amplifiers for today’s smart cockpits.
Morning Overview on MSN
Scientists "cured" Alzheimer's in mice, are humans next?
Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...
A new technical paper titled “Hybrid tungsten oxyselenide/graphene electrodes for near-lossless 2D semiconductor phase ...
Scientists have uncovered a way to manipulate the pathway in monkey brains that puts the brakes on motivation.
The Politecnico di Milano has created the first integrated and fully tunable device based on spin waves, opening up new ...
Power management is one of the keys for developing successful semiconductors products. There are virtually no applications ...
Practice CBSE Class 12 Physics Top 50 MCQs with Answers based on the latest syllabus and exam pattern. Prepare effectively ...
Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
Two NDA submissions expected by mid-February 2026 for ulixacaltamide in essential tremor and relutrigine in SCN2A/8A-DEEs, both with Breakthrough ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback